M1A.262 Drug-induced chronic gout, left knee

Name of the Condition

• Drug-Induced Chronic Gout, Left Knee

Summary

Drug-induced chronic gout, left knee is a form of arthritis affecting the left knee joint, resulting from prolonged elevated uric acid levels due to medication use. It leads to recurrent joint inflammation and potential tissue damage, characterized by persistent symptoms and may involve the formation of tophi (urate crystal deposits) in advanced stages.

Causes

This condition arises from medications that interfere with uric acid metabolism or excretion, causing accumulation in the blood. Over time, urate crystals deposit in the left knee joint and surrounding tissues, triggering inflammation. Common culprits include diuretics, low-dose aspirin, and certain chemotherapy agents.

Risk Factors

• Use of medications that increase uric acid levels (e.g., diuretics, low-dose aspirin)
• Prolonged exposure to urate-raising drugs
• Pre-existing hyperuricemia or gout history
• Renal impairment affecting drug clearance

Symptoms

• Recurrent episodes of intense left knee pain, often with swelling and redness
• Persistent warmth and tenderness in the affected knee
• Formation of tophi (hard, painless lumps) around the knee joint
• Stiffness and limited range of motion in the left knee
• Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests, and imaging. Blood tests assess uric acid levels, while joint fluid analysis confirms urate crystal presence. Imaging (e.g., X-ray, ultrasound) evaluates joint damage and tophi. Clinical history of medication use and symptom patterns supports the diagnosis.

Treatment Options

Treatment focuses on reducing uric acid levels and managing inflammation. Medications may include urate-lowering agents (e.g., allopurinol) and anti-inflammatories (e.g., colchicine, NSAIDs). Lifestyle modifications, such as dietary changes and hydration, complement pharmacologic therapy. In severe cases, corticosteroids or surgery may address tophi or joint damage.

Prognosis and Follow-Up

Prognosis depends on early intervention and adherence to treatment. Chronic management prevents further joint damage and reduces flare frequency. Regular follow-up monitors uric acid levels, kidney function, and medication efficacy. Untreated cases may progress to severe arthritis or tophi formation.

Complications

• Chronic joint damage or deformity
• Tophi formation leading to functional impairment
• Kidney stones or renal impairment from uric acid deposition
• Increased risk of acute gout flares

Lifestyle & Prevention

• Avoid medications known to raise uric acid (if possible)
• Maintain a balanced diet low in purines (e.g., limit red meat, alcohol)
• Stay hydrated to support uric acid excretion
• Manage weight and exercise regularly to reduce joint stress

When to Seek Professional Help

Seek care if experiencing severe or persistent left knee pain, swelling, or redness. Prompt evaluation is needed for sudden symptom worsening, fever, or inability to bear weight. Early intervention prevents long-term complications.

Tips for Medical Coders

Document the specific joint (left knee) and confirm drug-induced etiology. Include details on tophi presence or absence, as applicable, to ensure accurate coding. Verify that the diagnosis aligns with clinical findings and medication history.